Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Rivoglitazone in Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00484198

Public ClinicalTrials.gov record NCT00484198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo and Active Comparator-Controlled, Parallel-Group Study of the Efficacy and Safety of Rivoglitazone as Monotherapy Treatment of Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT00484198
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
1,912 participants

Conditions and interventions

Interventions

  • Pioglitazone Drug
  • Placebo Drug
  • Rivoglitazone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2007
Primary completion
Feb 11, 2009
Completion
Feb 11, 2009
Last update posted
Jul 26, 2021

2007 – 2009

United States locations

U.S. sites
70
U.S. states
28
U.S. cities
70
Facility City State ZIP Site status
Not listed Anniston Alabama
Not listed Birmingham Alabama
Not listed Hoover Alabama
Not listed Muscle Shoals Alabama
Not listed Hot Springs Arkansas
Not listed Jonesboro Arkansas
Not listed Little Rock Arkansas
Not listed Buena Park California
Not listed Garden Grove California
Not listed Huntington Park California
Not listed Los Angeles California
Not listed Paramount California
Not listed Sacramento California
Not listed San Diego California
Not listed Walnut Creek California
Not listed West Covina California
Not listed West Hills California
Not listed Denver Colorado
Not listed Delray Beach Florida
Not listed Jacksonville Florida
Not listed Merritt Island Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed Tampa Florida
Not listed Honolulu Hawaii
Not listed Boise Idaho
Not listed Chicago Illinois
Not listed Evansville Indiana
Not listed Indianapolis Indiana
Not listed Wichita Kansas
Not listed Madisonville Kentucky
Not listed New Orleans Louisiana
Not listed Slidell Louisiana
Not listed Springfield Massachusetts
Not listed Portage Michigan
Not listed Southfield Michigan
Not listed St Louis Missouri
Not listed Voorhees Township New Jersey
Not listed Syracuse New York
Not listed Morehead City North Carolina
Not listed Salisbury North Carolina
Not listed Statesville North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Cleveland Ohio
Not listed Delaware Ohio
Not listed Lyndhurst Ohio
Not listed Marion Ohio
Not listed Oklahoma City Oklahoma
Not listed Tulsa Oklahoma
Not listed Portland Oregon
Not listed Beaver Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Charleston South Carolina
Not listed Columbia South Carolina
Not listed Cleveland Tennessee
Not listed Kingsport Tennessee
Not listed New Tazewell Tennessee
Not listed Carrollton Texas
Not listed Conroe Texas
Not listed Corpus Christi Texas
Not listed Dallas Texas
Not listed El Paso Texas
Not listed Garland Texas
Not listed Irving Texas
Not listed Midland Texas
Not listed San Antonio Texas
Not listed Richmond Virginia
Not listed Olympia Washington
Not listed Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 113 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00484198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2021 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00484198 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →